Gene · 776
Papers2,356
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,356
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bending the boundaries: the many facets of endophilin-As from membrane dynamics to disease. | Cell Mol Life Sci | 2025 | 40986063 | PubTator, text mining | PubMed |
| Sclareol and cinnarizine are non-selective inhibitors of voltage-gated Cav1.3 L-type Ca2+ channels. | Channels (Austin) | 2025 | 40957616 | PubTator, text mining | PubMed |
| Is CABP2-Associated Hearing Loss (DFNB93) a Gene Therapy Target? Preclinical Progress and Patient Registry. | MedComm (2020) | 2025 | 40927552 | PubTator, text mining | PubMed |
| Targeting macrophages and ion homeostasis in T2D: new genes and therapeutic pathways identified. | Front Immunol | 2025 | 40895573 | PubTator, text mining | PubMed |
| Heart Rate Variability Alterations During Delayed-Onset Muscle Soreness-Inducing Exercise-With Piezo2 Interpretation. | Sports (Basel) | 2025 | 40863771 | PubTator, text mining | PubMed |
| New perspectives on molecular mechanisms underlying exercise-induced benefits in Parkinson's disease. | NPJ Parkinsons Dis | 2025 | 40849310 | PubTator, text mining | PubMed |
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Characterization of congenital hyperinsulinism in Argentina: Clinical features, genetic findings, and treatment outcomes. | PLoS One | 2025 | 40828772 | PubTator, text mining | PubMed |
| Histopathological features of aldosterone-producing lesions according to their different somatic genetic mutations. | Vitam Horm | 2025 | 40812944 | PubTator, text mining | PubMed |
| Gene therapy downregulating CaV1.3 reverses motor disability in aged parkinsonian male and female macaques. | Mol Ther | 2025 | 40782791 | PubTator, text mining | PubMed |
| Cosyntropin-Stimulated Aldosterone Reserve of the Nondominant Adrenal Predicts Surgical Outcomes in Primary Aldosteronism. | Hypertension | 2025 | 40755305 | PubTator, text mining | PubMed |
| Pharmacogenomic insights into amlodipine response: the role of CACNA1D, CACNA1C, and TRIB3 variants in hypertensive patients. | PLoS One | 2025 | 40748902 | PubTator, text mining | PubMed |
| Modulating intracellular calcium dynamics with alkaloids: A novel strategy against oxidative neurodegeneration. | Toxicol Res (Camb) | 2025 | 40718852 | PubTator, text mining | PubMed |
| Mechanistic investigation of methadone, tolfenamic acid, and cilnidipine in traumatic brain injury: a novel multi-target perspective outcome of network pharmacology. | Inflammopharmacology | 2025 | 40622465 | PubTator, text mining | PubMed |
| Synergy between RNA editing and alternative splicing modulates the biological properties of the voltage-gated calcium channel CaV1.3. | J Biol Chem | 2025 | 40581120 | PubTator, text mining | PubMed |
| Whole Exome Sequencing in 26 Saudi Patients Expands the Mutational and Clinical Spectrum of Diabetic Nephropathy. | Medicina (Kaunas) | 2025 | 40572705 | PubTator, text mining | PubMed |
| Role of Cav1.3 Channels in Brain-Heart Interactions: An Unexpected Journey. | Biomedicines | 2025 | 40564095 | PubTator, text mining | PubMed |
| Histopathological spectrum of common aldosterone-driver gene mutations in aldosterone-producing adenomas. | Front Med (Lausanne) | 2025 | 40557039 | PubTator, text mining | PubMed |
| Adrenal causes of endocrine hypertension in childhood or adolescence. | J Endocrinol Invest | 2025 | 40540150 | PubTator, text mining | PubMed |
| Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours. | Endocr Connect | 2025 | 40531063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/776/papers?page=4